World's Best Scientists 2026 revealed!
Michael A. Pulsipher

Michael A. Pulsipher

D-Index & Metrics

Medicine

D-Index
83
Citations
28046
World Ranking
15516
National Ranking
7821

Michael A. Pulsipher publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michael A. Pulsipher sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 552 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michael A. Pulsipher D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michael A. Pulsipher sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 83 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michael A. Pulsipher is affiliated with the University of Utah in the United States. Their research primarily focuses on medicine, with substantial contributions to hematology, oncology, immunology, public health, environmental and occupational health, and genetics. Their work encompasses several specialized topics related to hematopoietic stem cell transplantation, CAR-T cell therapy research, and various forms of leukemia, particularly acute lymphoblastic leukemia (ALL).

The scientist has contributed extensively to research on these main topics:

  • Hematopoietic Stem Cell Transplantation
  • CAR-T cell therapy research
  • Acute Lymphoblastic Leukemia research
  • Immunodeficiency and Autoimmune Disorders
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • Immune Cell Function and Interaction

Michael A. Pulsipher has published numerous papers in well-regarded journals. Some recent publications include:

  • Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma, 2020, Blood Advances
  • Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia, 2021, JAMA
  • Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial, 2022, Journal of Clinical Oncology
  • Immunogenicity of CAR T cells in cancer therapy, 2021, Nature Reviews Clinical Oncology
  • Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD, 2021, Journal of Clinical Oncology

Their work frequently appears in several publication venues, including:

  • Blood
  • Transplantation and Cellular Therapy
  • Blood Advances
  • Biology of Blood and Marrow Transplantation
  • Clinical Immunology

Michael A. Pulsipher collaborates regularly with several researchers. Frequent co-authors include:

  • Christopher C. Dvorak
  • Sung-Yun Pai
  • Brent R. Logan
  • Donald B. Kohn
  • Élie Haddad

Best Publications

  • Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

    S. L. Maude;Theodore W Laetsch;J. Buechner;S. Rives

  • Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller

  • Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

    Sung Yun Pai;Brent R. Logan;Linda M. Griffith;Rebecca H. Buckley

  • Comorbidity-Age Index: A Clinical Measure of Biologic Age Before Allogeneic Hematopoietic Cell Transplantation

    Mohamed L. Sorror;Rainer F. Storb;Brenda M. Sandmaier;Richard T. Maziarz

  • Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma.

    Marcelo C. Pasquini;Zhen-Huan Hu;Kevin Curran;Theodore Laetsch

  • HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.

    Michael B. Maris;Dietger Niederwieser;Brenda M. Sandmaier;Barry Storer

  • Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

    Michael B. Maris;Brenda M. Sandmaier;Barry E. Storer;Thomas Chauncey

  • Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma

    Lauri M. Burroughs;Paul V. O'Donnell;Brenda M. Sandmaier;Barry E. Storer

  • Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

    Mohamed L. Sorror;Barry E. Storer;Brenda M. Sandmaier;Michael Maris

  • Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

    Mohamed Sorror;Barry Storer;Barry Storer;Brenda M. Sandmaier;Brenda M. Sandmaier;David G. Maloney;David G. Maloney

  • Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program

    Michael A. Pulsipher;Pintip Chitphakdithai;John P. Miller;Brent R. Logan

  • Long-Term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies

    Mohamed L. Sorror;Brenda M. Sandmaier;Brenda M. Sandmaier;Barry E. Storer;Barry E. Storer;Georg N. Franke

  • Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.

    Selina M. Luger;Olle Ringdén;Mei-Jie Zhang;Waleska S. Pérez

  • The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex.

    Gary M. Kupfer;Dieter Näf;Ahmed Suliman;Michael Pulsipher

  • Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.

    Jennifer Heimall;Brent R. Logan;Morton J. Cowan;Luigi D. Notarangelo

  • Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning for Advanced Chronic Lymphocytic Leukemia

    Mohamed L. Sorror;Michael B. Maris;Brenda M. Sandmaier;Barry E. Storer

  • Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

    Naynesh R. Kamani;Mark C. Walters;Shelly Carter;Victor Aquino

  • Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial

    Patrick A. Brown;Lingyun Ji;Xinxin Xu;Meenakshi Devidas

  • Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia

    Boglarka Gyurkocza;Rainer Storb;Barry E. Storer;Thomas R. Chauncey

  • Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

    Rainer Storb;Boglarka Gyurkocza;Boglarka Gyurkocza;Barry E. Storer;Barry E. Storer;Mohamed L. Sorror;Mohamed L. Sorror

Frequent Co-Authors

Brenda M. Sandmaier
Brenda M. Sandmaier Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
Brent R. Logan
Brent R. Logan Medical College of Wisconsin
Stephan A. Grupp
Stephan A. Grupp Children's Hospital of Philadelphia
John E. Levine
John E. Levine Icahn School of Medicine at Mount Sinai
Richard T. Maziarz
Richard T. Maziarz Oregon Health & Science University
Mary M. Horowitz
Mary M. Horowitz Medical College of Wisconsin
Michael Boyer
Michael Boyer University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in the healthcare field but aren’t set on medical school, several flexible online degrees can jumpstart your career. Many students explore affordable online nursing programs, which offer quality education at a lower cost and often allow you to study while working.

For those who already hold a registered nursing license, an rn to bsn online cost comparison can help you find budget-friendly options to advance your qualifications. If you’re aiming higher, consider online nursing doctoral programs for a fast track to leadership or research roles.

Professionals with a bachelor’s degree in another field can enter the profession quickly through online msn programs for non nurses, offering direct entry into nursing with minimal prerequisites. As the demand for skilled healthcare professionals grows, choosing the right online path can open up new opportunities in patient care, administration, teaching, or research.

Discover a range of online nursing doctoral programs designed for working adults—further proof that you don’t need to put your life on hold to advance your career in healthcare.

Best Scientists Citing Michael A. Pulsipher

Trending Scientists

Recently Published Articles